Antineoplastic Agents

DBCAT000024Pharmacologic classL01

Substances that inhibit or prevent the proliferation of NEOPLASMS. A DrugBank category of 786 drugs. 365 of them are approved.

ATC classification: L — ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 — ANTINEOPLASTIC AGENTS
Also known as: Agents, Anticancer · Agents, Antineoplastic · Agents, Antitumor · Agents, Cancer Chemotherapy · Agents, Chemotherapeutic Anticancer
Drugs: 10-hydroxycamptothecin
2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide
2-chloroethyl-3-sarcosinamide-1-nitrosourea
2-Methoxyestradiol
3,4-Dihydroxybenzoic Acid
4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide
5,6-dihydro-5-azacytidine
5'-S-methyl-5'-thioadenosine
6-diazo-5-oxo-L-norleucine
6-O-benzylguanine
7-Hydroxystaurosporine
8-azaguanine
9-aminocamptothecin
Abagovomab
Abemaciclib
Abexinostat
Abiraterone
ABSK-091
Acalabrutinib
Acemannan
Acetyldinaline
Acivicin
Aclarubicin
Acridine Carboxamide
Acronine
and 761 more with a free account

What you can answer from here — as of October 27, 2022

786DrugsEach linked to its full drug card

813Drug targetsEvery drug–target pair in the class, with bond type

29,692Marketed productsAcross the regions we cover, with dosage forms and routes

52Routes of administrationHow the drugs in this class are given

17SubcategoriesNarrower classes within this one

Which targets do Antineoplastic Agents share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.